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Abstract
Background: The aim of the present research is to conduct a fully powered explanatory trial to evaluate the
efficacy of a brief self-regulation intervention to increase walking. The intervention will be delivered in primary care
by practice nurses (PNs) and Healthcare Assistants (HCAs) to patients for whom increasing physical activity is a
particular priority. The intervention has previously demonstrated efficacy with a volunteer population, and
subsequently went through an iterative process of refinement in primary care, to maximise acceptability to both
providers and recipients.
Methods/ Design: This two arm cluster randomised controlled trial set in UK general practices will compare two
strategies for increasing walking, assessed by pedometer, over six months. Patients attending practices randomised
to the self-regulation intervention arm will receive an intervention consisting of behaviour change techniques
designed to increase walking self-efficacy (confidence in ability to perform the behaviour), and to help people
translate their “good” intentions into behaviour change by making plans. Patients attending practices randomised
to the information provision arm will receive written materials promoting walking, and a short unstructured
discussion about increasing their walking.
The trial will recruit 20 PN/HCAs (10 per arm), who will be trained by the research team to deliver the self-
regulation intervention or information provision control intervention, to 400 patients registered at their practices
(20 patients per PN/HCA). This will provide 85% power to detect a mean difference of five minutes/day walking
between the self-regulation intervention group and the information provision control group. Secondary outcomes
include health services costs, and intervention effects in sub-groups defined by age, ethnicity, gender, socio-
economic status, and clinical condition. A mediation analysis will investigate the extent to which changes in
constructs specified by the Theory of Planned Behaviour lead to changes in objectively assessed walking behaviour.
Discussion: This trial addresses the current lack of evidence for interventions that are effective at increasing
walking and that can be offered to patients in primary care. The intervention being evaluated has demonstrated
efficacy, and has been through an extensive process of adaptation to ensure acceptability to both provider and
recipient, thus optimising fidelity of intervention delivery and treatment receipt. It therefore provides a strong test
of the hypothesis that a self-regulation intervention can help primary care patients increase their walking.
Trial registration: Current Controlled Trials ISRCTN95932902
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Background
The Department of Health for England currently recom-
mends that individuals should engage in at least 30 min-
utes of “moderate or vigorous” exercise, for at least five
days each week, to gain health protective benefits [1].
Over 60% of men and 70% of women in England and
Wales do not report meeting these requirements, and
the proportion who actually meet them is likely to be
considerably lower [2]. The Chief Medical Officer for
England has recognised that many people have difficulty
in translating a physical activity recommendation into
daily life [3].
Brisk walking (i.e. walking of sufficient intensity to
result in the walker getting slightly out of breath) is a
form of moderate physical activity which is especially
promising for health promotion because of its accept-
ability and accessibility, particularly among populations
who are the most physically inactive [4]. It does not
have to be scheduled, nor does it require any special
clothes or equipment, so it is relatively low cost.
Further, walking is low impact so minimises the risk of
injuries and does not cause as much anxiety regarding
adverse effects in sedentary populations as more vigor-
ous forms of physical activity. There is meta-analytic
evidence that increases in walking in previously seden-
tary adults increase fitness, and decrease body weight,
BMI, percentage body fat and resting diastolic blood
pressure [5]. That is, not only is walking acceptable to
sedentary people, but it affords them considerable health
benefits.
A recent systematic review and meta-analysis of 19
randomised and 29 non-randomised controlled studies
provided evidence of the potential efficacy of walking
interventions [6]. It concluded that “the most successful
interventions could increase walking among targeted
participants by up to 30-60 minutes a week on average,
at least in the short term” [6]. The usefulness of this
review was limited by including a mix of different types
of interventions targeted at different populations, using
different modes of delivery and different assessments of
change in walking, which makes it difficult to identify
the most effective intervention strategies. In addition the
extent to which these interventions were sustainable,
generalisable, or cost-effective is unclear, making inter-
pretation to inform policy difficult.
A 2006 review from the National Institute of Health
and Clinical Excellence (NICE) concluded that, although
there is considerable evidence for the benefits that
accrue from walking, there is a shortage of effective
interventions that can be offered to patients in primary
care [7]. This conclusion was unchanged when
the review was updated in 2011. The advantages of a
primary care setting are that this is where most of the
population has regular contact with the healthcare
system, and often in circumstances where they are
receptive to advice to alter their behaviour. There has
also been increased delivery of lifestyle advice by prac-
tice nurses (PNs) and healthcare assistants (HCAs),
based in, or working closely with primary care. If an
intervention to increase walking in primary care is effec-
tive and cost-effective, then primary care offers the pos-
sibilities of scaling this up to allow a large proportion of
the population to receive the benefits of being more
physically active.
The present study protocol describes a cluster rando-
mised controlled trial of an intervention to increase
walking in primary care which was designed to address
the lack of effective interventions that can be offered to
patients identified by NICE. In line with the Medical
Research Council (MRC) framework for development
and evaluation of complex interventions [8,9], the trial
intervention and procedures build on previous formative
research [10-14], based on explicit theory [15-17].
Extended developmental work was conducted using
the Theory of Planned Behaviour (TPB), a social cogni-
tion model which can be used to predict and explain
any behaviour in terms of a limited set of constructs
[15]. A review of previous research using this theory
identified perceived behavioural control (PBC) as the
strongest predictor of intentions to walk more [13].
According to the TPB, PBC is underpinned by control
beliefs: beliefs about which factors make it easy or diffi-
cult to perform the behaviour [15]. The most common
control beliefs regarding walking in a general public
sample [10] were identified as related to lack of time,
indicating that the intervention should aim to address
these beliefs. As PBC is a highly similar, if not identical,
construct to self-efficacy [18], the literature on altering
self-efficacy was consulted [16], which suggested that
mastery experience was likely to be effective [16].
It is now well recognised that there is often a “gap”
between intentions and behaviour [19]. Consequently,
this intervention included not only a motivational
component, to increase the intention to walk more, but
also a volitional arm to enact those intentions [20]. This
may be particularly important for walking, as the asso-
ciation between intentions and behaviour has been
found to be low in past research [11]. This may be due
to people reporting walking as being a means to achieve
other goals, rather than a goal in itself, which is the case
with many other forms of physical activity [12].
The formative research led to the development of a
single session intervention of 15 minutes duration. It
consists of techniques to increase self-efficacy (confi-
dence in ability to perform the behaviour), and planning
techniques to help people translate their “good
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intentions” into behaviour change [14]. This was done
by, e.g. asking participants to recall previous walking
successes [16] and by forming action plans about when,
where, how and with whom they would increase their
walking [17,20].
An evaluation of this intervention with 130 adult
volunteers showed that it yielded large increases
(Cohen’s d = 0.90) in objectively assessed walking beha-
viour [14]. The mean increase of 87 minutes/week com-
pares favourably with the mean increase of 30-60
minutes/week among the “most successful interventions”
to promote walking identified by Ogilvie and colleagues
[6]. These increases in objectively assessed behaviour
were mediated by changes in walking self-efficacy, in
line with the theoretical basis of the intervention, and
were maintained for at least six weeks post-intervention.
Further, similarly large effects on objectively assessed
walking behaviour (d = 1.06) were obtained when the
intervention was delivered to another volunteer sample
by a person who was not involved in its development,
indicating that the observed effects were due to the
intervention itself, rather than the person delivering it
[21]. The mechanism by which the intervention worked
appeared again to be due to increasing self-efficacy, with
little apparent effect of the intervention on self-reported
planning [21].
The intervention was further developed following a
subsequent meta-analysis that examined which interven-
tion techniques [22] were associated with improvements
in self-efficacy for increasing physical activity [23]. The
technique of providing structured feedback was identi-
fied in the review as being associated with improve-
ments in self-efficacy [23]. It was not included in the
original intervention but has since been added to
enhance the intervention’s effectiveness. In addition, the
technique of coping planning [17], which includes iden-
tification of barriers to physical activity, was removed,
given that barrier identification was associated with
poorer self-efficacy in the review. It was notable that
those techniques which were associated with increases
in self-efficacy were the same techniques which were
associated with increases in physical activity (r = 0.69),
providing further support for the idea that self-efficacy
is a key determinant of such interventions [24].
The walking intervention has subsequently been
extensively refined for delivery in primary care. A key
aim of this refinement was to ensure provider fidelity of
delivery to the intervention manual, and maximise reci-
pient fidelity of receipt and enactment of the interven-
tion techniques. If interventions are not delivered or
received as intended (i.e. as per protocol) then it is diffi-
cult, if not impossible to be certain that the results can
be attributed to the intervention itself [25]. This devel-
opmental work therefore tried to retain those key
principles and elements of an intervention which had
already demonstrated efficacy when delivered outside of
a healthcare system to adult volunteers, and also opti-
mise acceptability to both recipients and providers.
Three phases of development work were conducted,
before the current trial.
First, the intervention was revised, in an iterative fash-
ion. A Research Nurse who was part of the research
team delivered the intervention, based on an explicit
manual, to patients in a single primary care practice
within a local healthcare organisation, Coventry Primary
Care Trust (PCT). Each intervention session was
recorded, along with a brief interview with the interven-
tion recipient conducted by a different research team
member at the end of the intervention. On the basis of
problems arising, the intervention was revised following
discussion by the research team. The intervention was
then further delivered, and revised, until it had been
delivered to 10 patients, to optimise acceptability of the
intervention to the patient recipients.
Secondly, two PNs and one HCA were trained, each
delivering the intervention to four patients in their prac-
tices. The PN/HCAs were also interviewed prior to, and
after, both the training and delivery to assess acceptabil-
ity of the training and intervention materials. A sample
of patients was also interviewed to establish comprehen-
sion and acceptability of the intervention. The training
and intervention materials were then revised to optimise
acceptability to PNs/ HCAs delivering the intervention.
Thirdly, an exploratory (pilot) trial was conducted,
with 10 PNs/ HCAs recruited and trained, and eight
delivering the intervention to up to 15 patients per prac-
tice. Two PNs were recruited and trained to deliver the
control intervention to up to 15 patients per practice. In
total, 66 intervention patients and 20 control patients
participated. Data from three sources were collected
during this pilot trial to assess treatment fidelity in rela-
tion to delivery and receipt of the intervention and to
investigate reasons for variation in fidelity. Taped inter-
vention sessions are being analysed to quantify the
extent to which each intervention technique was deliv-
ered as specified by the intervention manual. Eight PN/
HCAs were interviewed after they completed delivery of
the intervention to investigate their experiences of deli-
vering the intervention. Twelve patients were inter-
viewed immediately after receiving the intervention, and
three months later, to investigate patients’ experiences
of participating in the intervention, and specifically how
the intervention was received.
The main outcome of this developmental work in
primary care was that the intervention was refined, so as
to be acceptable to both recipients and providers. We
believe this work has provided a solid foundation of
intervention development, based on an intervention with
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demonstrated efficacy in increasing objectively assessed
walking and extensive adaptation to fit the primary care
context, whilst retaining its theoretical underpinning.
The next stage of this research is to examine the extent
to which this developmental work has resulted in an
intervention which can demonstrate efficacy in changing
the walking behaviour of patients, when delivered in
general practices by Practice Nurses or Health Care
Assistants (PN/HCAs). In addition, it is unclear to what
extent any intervention effects are sustainable and cost-
effective, making interpretation to inform policy
difficult.
The overall aims of the present research therefore,
are to conduct a fully powered, definitive explanatory
trial to:
(a) Assess the efficacy of the intervention in chan-
ging objectively assessed walking behaviour, for up
to six months post-intervention.
(b) Identify key intervention mechanisms.
(c) Estimate the difference in the cost of the
resources used by patients in each arm of the trial,
and the cost-effectiveness of the intervention.
Methods/Design
Study Design
This explanatory trial is a two-arm cluster randomised
controlled trial, with clustering by GP practice. It will
assess differences in objectively assessed walking
between patients who receive a brief self-regulation
intervention, compared with patients who are provided
with information about the benefits of walking. PNs/
HCAs randomised to the intervention group will deliver
a brief self-regulation intervention to eligible patients,
targeting self-efficacy and planning. PNs/ HCAs rando-
mised to the “information provision” control group will
provide information to eligible patients using materials
which are currently widely available.
The study protocol was approved by Birmingham East,
North and Solihull Research Ethics Committee (REC
Ref: 09/H1206/116).
Sample size
A total of 400 patients will be recruited from 20 PNs/
HCAs (10 in each trial arm), each delivering the walking
intervention sessions to 20 patients. Assuming a stan-
dard deviation of walking of 15 minutes/day, as obtained
in a previous study with adult volunteers [14] and an
intraclass correlation coefficient of 0.010, equal to the
median value found in a review of clustering effects in
practices in primary care [26], this will provide 85%
power to detect a mean difference of five minutes/day
walking between the intervention group, and the control
group.
The difference in walking between groups that this
explanatory trial is powered to detect is smaller than
that observed in a previous study with adult volunteers
[14] (12.4 mins/day over the first week, Cohen’s d =
0.90) due to participants being primary care patients
rather than volunteers, there being lower anticipated
fidelity of treatment delivery, and a longer duration of
outcome follow up.
Setting/ participants
The study will take place in primary care practices in a
geographically and socially diverse sub-region of central
England (Coventry, Warwickshire, Worcestershire, and
Herefordshire PCTs).
Practice Nurses/ Health Care Assistants
PNs/ HCAs in both the intervention and control arms
will deliver sessions within the practices in which they
are employed, to registered patients. All PNs/ HCAs
who are randomised to the intervention group will be
trained by the research team, and demonstrate compe-
tence to deliver the intervention, as assessed by the
research team (details provided below) before delivering
the intervention to patient participants. All PN/ HCAs
randomised to the control group will be provided with
one to one training on the control intervention and trial
procedures from a member of the research team, usually
involving one visit to their practice of approximately one
hour. The PN/HCAs in the control arm will be offered
the opportunity to receive training in the self-efficacy
plus planning intervention after all participating patients
from their practices have completed the 6 month fol-
low-up measures.
Patients
To be eligible for inclusion in the trial, potential partici-
pants must be patients in a participating practice, as
well as:
a) be aged between 16 and 65 years old,
b) have one of the following chronic conditions
where physical activity has been shown to have a
positive effect on health status [1]: hypertension,
type 2 diabetes, pre-diabetes (impaired glucose toler-
ance, insulin resistance), low back pain, fibromyalgia,
coronary heart disease, cardio-vascular disease,
hypercholesterolemia, osteoporosis and osteoarthri-
tis, or are overweight or obese,
c) not currently being investigated/treated by sec-
ondary care specialists for the condition (s) or are
awaiting investigation/treatment by secondary care
specialists for the condition (s),
d) are “sedentary” in terms of not meeting the
30 mins/day at least 5 times/ week guidelines [1],
e) are able to speak English (and therefore could
potentially benefit from the PN/ HCA intervention
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session). This is because the intervention is to be
delivered and interpreted verbally and there are not
sufficient resources to employ interpreters. Where
participants cannot adequately read English, the
PN/HCA will read the patient information sheet,
consent form and worksheet instructions.
f) do not have learning difficulties that would pre-
clude active engagement with the intervention
session,
g) do not have mental health problems i.e. anxiety,
depression that would preclude active engagement
with the intervention session, or where the patient is
being investigated/treated by secondary care specia-
lists for the problem,
h) wish to participate,
i) receive a letter of invitation to the study from
their practice.
Study intervention
Self-regulation intervention
Participants will receive the intervention in two face-
to-face sessions, one week apart, with a telephone or
face to face follow-up two weeks after the second ses-
sion. The choice of face to face or telephone follow up
will be decided by the PN/HCA in consultation with
the patient, and will be dependent on the patient’s
and PN/HCA’s own preference. Each session may be
up to 30 minutes in duration, although it is antici-
pated that the follow-up session will be shorter. The
intervention is fully detailed in the intervention man-
ual, a copy of which is available on request from the
first author.
Session one consists of motivational techniques to
increase the patients’ self-efficacy [16] about their abil-
ity to increase their walking, by requiring them to
rehearse previous instances where they have success-
fully managed to complete long walks, or where they
found such walks easy [27]. It also includes volitional
techniques to facilitate realistic goal setting [28], and
to translate intentions into practice (e.g. action plans)
[17,20]. Session two consists of a review of progress
since session one, involving positive feedback in rela-
tion to effort and achievement, and possible revision of
goals set and action plans. It also includes the voli-
tional technique of supportive/ facilitative planning,
whereby the participant is encouraged to identify what
factors support increased walking, and make plans to
bring about those factors [14]. In this sense, it is
similar to coping planning [17], but with a focus on
how to increase and strengthen helpful factors, rather
than how to overcome barriers. The follow-up session
consists of an abbreviated version of some of the same
techniques delivered in session two.
Training and fidelity assurance of self-regulation
intervention
Each walking intervention PN/ HCA will be trained
using the training manual and materials that have been
developed, and refined in earlier phases of this research.
All PN/HCAs will complete two training sessions, total-
ling seven hours. Training will involve formal presenta-
tions to introduce the PN/HCAs to the theory and
research underpinning the intervention and the essential
elements of the intervention: participative learning, prac-
tising delivery of intervention techniques, observation,
feedback, discussion and homework. All PN/HCAs will
become familiar with the intervention manual and mate-
rials. The training sessions will be conducted one week
apart to allow PN/HCAs to absorb and reflect on what
they have learnt and to re-read through the intervention
materials.
After participating in the training sessions, PN/HCAs
will be observed delivering both intervention sessions to
either a colleague or acquaintance of the PN/HCA, or a
researcher/ administration officer from Coventry
University. Their competences will be assessed using
20-point checklists of intervention behaviours, rated by
a member of the study team. To be certified competent
in delivering the intervention, PN/HCAs need to achieve
a minimum score of 15 out of a possible score of 20 for
both sessions. PNs/HCAs will only deliver the interven-
tion as part of the main trial after achieving this level of
competence. Where the minimum level of competence
is not achieved, the PN/HCA will be given feedback on
potential areas for improvement and asked to repeat the
assessment of competence on a later occasion. Irrespec-
tive of whether the minimum level is achieved, feedback
on delivery will be given, with emphasis on where good
performance has been achieved, as well as where
improvement is possible, to both encourage and inform
future delivery.
Information provision control intervention
The PN/HCA will give their patients an information
pack of materials promoting walking produced by the
British Heart Foundation and Walking the Way to
Health. The PN/HCA will answer any questions the
patient may have about walking more, and continue
to provide usual care for that patient with regard to
walking.
Outcome measures
The main outcome measure will be mean daily number
of minutes walked in the past week, assessed at all time
points using the New Lifestyles NL-1000 Activity Moni-
tor Pedometer (New-Lifestyles Inc, Lees Summit, Mis-
souri, USA). This pedometer provides readings on
number of minutes walked and step counts, over each
of the previous seven days. The intensity threshold of
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each pedometer will be set to record movement on a
setting of four or above (the range is 1 to 9), to assess
physical activity of at least moderate intensity.
Psychological process will be assessed using one of
two Theory of Planned Behaviour (TPB) [15] question-
naires, both of which measure several constructs. A
longer 26-item version measures intentions, self efficacy/
PBC, attitudes, subjective norms, control beliefs and
associated perceived power to inhibit/ facilitate beha-
viour in relation to walking for at least 30 minutes on
average a day over the next 7 days [29]. A brief 6-item
version of the questionnaire assesses only intentions, self
efficacy/ PBC, attitudes, and subjective norms. Both ver-
sions of the TPB questionnaire are abbreviated versions
of measures previously developed [10] and validated
[13,14] in studies of walking with an adult volunteer
general public sample.
Data on NHS resource use and personal costs to
patients will be collected using standard measures for
economic analysis [30]. Impact on Quality of Life will
also be assessed using the EQ-5D questionnaire [31,32].
Comparing this with costs (directly and indirectly
related to patient management) will enable incremental
cost-effectiveness of the intervention to be estimated.
Trial procedures
Practice recruitment
Practices in the relevant PCTs will be contacted by the
study team, with the support of the local West Midlands
(South) Primary Care Research Network (PCRN). Prac-
tices will be sent an invitation letter and short informa-
tion sheet via the post, and this will be followed up by a
telephone call. The research team will provide additional
information to those practices that are interested,
including a consent form for PN/HCAs, which provide a
clear description of what is involved in participating in
the trial. Practices will be randomised to the self-regula-
tion intervention arm or to the information provision
control arm. Randomisation will only proceed after the
explicit agreement from the practice manager or a GP
principal has been obtained, and the relevant PN/HCA
has consented to delivering an intervention to 20
patients. Practices will be recruited on the understand-
ing that if they are allocated to the control arm (which
would still constitute good routine care), they will be
offered training in the self-regulation intervention upon
completion of study follow-ups.
Practice randomisation
Randomisation will be at the practice level, and will be
stratified by practice size and index of deprivation
scores, as assessed by practice postcode [33]. Strata will
be defined according to whether the practices are above
or below the median practice list size of 6127 for the
four PCTs and whether the practice deprivation index is
above or below the median deprivation index of 27.85,
14.57, 15.51 and 17.55 respectively for Coventry, War-
wickshire, Worcestershire, and Herefordshire PCTs.
Randomisation will be performed by researchers at
Coventry University external to the study team using
materials prepared by the trial statistician (Stallard).
These researchers have four lists, one for each of the
four stratified groups: (a) small practices + high depriva-
tion, (b) small practices + low deprivation, (c) large
practices + high deprivation, (d) large practices + low
deprivation. Each list contains a random ordering of
“intervention” and “control” allocations. When the study
team receive a consent form from a PN/ HCA to con-
firm that their practice will enter into the trial, the
appropriate list will be consulted by the researchers
external to the study team, who will record the practice
name, and indicate whether they are intervention or
control.
Patient recruitment
An initial list of patients will be selected from practice
computerised records, using electronic searches, to iden-
tify eligible patients. A list of a random subsample of eli-
gible patients (initially 200) will be sent to the GP or PN
in each practice who will be nominated as responsible
for referring patients. They will be given the inclusion
criteria to guide recruitment.
Identified patients will be sent an invitation letter
addressed from the practice, which emphasises that the
intervention is intended for people who do less than the
recommended 30 minutes of moderate or vigorous phy-
sical activity on at least five days a week. They will also
be sent a patient information sheet explaining the study.
Patients who are interested in taking part will be
required to call the practice to make their first appoint-
ment with the PN/HCA delivering the intervention.
Contact details for further information about the study
will be included on the invitation letter and information
sheet. Where the initial post to 200 patients does not
yield 20 participating patients, further mail-outs to
another random sample of eligible patients will be made.
Patient consent, receipt of intervention, and follow-up
measurements
For both experimental conditions, each patient attends a
face-to-face session at their own practice with the PN/
HCA who is delivering the session. During this session,
they are screened for whether they already do more
than 30 minutes of moderate or vigorous physical activ-
ity per day on at least 5 days a week. If they are not
already achieving this recommended level of physical
activity, they are asked to provide informed consent,
and complete the baseline (t1) questionnaire, which
includes the full TPB measure, the EQ5D, and measures
of ethnicity, employment status and education level.
Information on patient date of birth, gender, and the
French et al. BMC Family Practice 2011, 12:56
http://www.biomedcentral.com/1471-2296/12/56
Page 6 of 10
clinical condition for which they were flagged (e.g. dia-
betes, hypertension, etc) will be recorded on a standar-
dised form by PN/HCAs. The form will be sent to the
research team, along with their contact details. Weight
and height information for each patient will be recorded
by the PN/HCA at baseline, which will allow calculation
of body mass index. After this point, the procedure dif-
fers for patients in practices allocated to the self-regula-
tion intervention condition, and patients in practices
allocated to the information provision condition (see
Figure 1).
For patients in practices allocated to the information
provision control condition, the session will continue
with delivery of the “information provision” interven-
tion as described above: the PN/HCA will provide
their patients with an information pack of materials
promoting walking, and answer any questions the
patient may have about walking more. At the end of
this session, patients complete the post-intervention
(t2) questionnaire, consisting of the brief TPB measure
only, and are given a pedometer, with detailed instruc-
tions in its use. They are asked to wear it for a week,
and return to the research team in a reply-paid envel-
ope. This forms the first post-intervention assessment
of walking.
For patients in practices allocated to the self-regula-
tion intervention condition, the PN/HCA provides their
patients with an information pack of materials promot-
ing walking, and answers any questions the patient may
have about walking more. Following this, two further
face-to-face appointments will be booked, for delivery of
the self-regulation intervention (as described above), at
one week and two weeks after this initial session, plus
the final intervention session four weeks after the initial
session. At the end of this session, patients are given a
pedometer, with detailed instructions for its use. They
are asked to wear it for a week, and return it at their
first intervention session where the PN/HCA will extract
the data from the pedometer. This initial assessment of
walking constitutes a pre-intervention measurement for
those patients in the intervention arm.
Patients in practices allocated to the intervention con-
dition then receive the self-regulation intervention, as
detailed above. Sessions one and two will be tape-
recorded, with the explicit agreement and signed con-
sent of the patients involved. At the end of the second
face-to-face session, patients complete the post-interven-
tion (t2) questionnaire, and are given a pedometer, to
wear for a week, and then return to the research team
in a reply-paid envelope. This forms the first post-inter-
vention assessment of walking.
Patients in practices allocated to the intervention con-
dition receive a final follow-up intervention session,
which may be by telephone or face-to-face, two weeks
after their second face-to-face session. Despite this, the
measurement procedures for patients in practices in
both conditions are identical from t2 onwards.
At six weeks post intervention (i.e. six weeks after t2
for both groups), all patients are sent a questionnaire by
post (t3) containing the brief TPB measure, and a ped-
ometer, and asked to return these by post. At six
months post intervention (t4), all patients are sent a
questionnaire containing a full TPB measure, the EQ5D,
and a final pedometer, which again they are asked to
return by post.
To encourage retention, all participants who complete
and return questionnaires or pedometers from t2
Information Provision control
PN/HCA n= 10
Self-regulation Intervention
PN/HCA n = 10
Identification and invitation of 20
eligible patients per practice
(Total patients n = 200)
N=20 PN/HCAs randomised by practice
Identification and invitation of 20
eligible patients per practice
(Total patients n = 200)
Baseline: informed consent and 
baseline questionnaire completed
t1 measures:
Full TPB questionnaire
Demographics
EQ5D
Information provision session, with
instructions on using pedometer
t3 measures (6 weeks post t2 
measures):
Short TPB questionnaire
Assessment of duration of 
walking (pedometer)
Baseline: informed consent and 
baseline questionnaire completed
t1 measures:
Full TPB questionnaire
Demographics
EQ5D
One week
First Intervention session
t4 measures (6 months post t2 
measures)
Full TPB questionnaire
EQ5D
Assessment of duration of 
walking (pedometer)
Information provision session, with
instructions on using pedometer
t2 measures:
Short TPB questionnaire 
Assessment of duration of walking 
(pedometer)
Two weeks 
Second Intervention session
t2 measures:
Short TPB questionnaire 
Assessment of duration of walking 
(pedometer)
Four weeks
Follow up Intervention session
Assessment of duration of walking 
(pedometer)
t3 measures (6 weeks post t2 
measures):
Short TPB questionnaire
Assessment of duration of 
walking (pedometer)
t4 measures (6 months post t2 
measures)
Full TPB questionnaire
EQ5D
Assessment of duration of 
walking (pedometer)
Figure 1 Flowchart showing planned study recruitment
numbers, and timing of intervention sessions and
measurements.
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onwards will be sent postal feedback on their walking
behaviour and psychological measurements in the form
of a postal profile. Those who do not send back the
pedometer at any measurement point will receive a
reminder letter and follow-up telephone calls from the
research team encouraging them to return these, as loss
of numerous pedometers will be expensive, and threaten
the validity of the study.
Analysis
Planned intention-to-treat comparisons of the two
groups at one week, six weeks and six months post-
intervention (i.e. six months after t2 for both groups)
will be conducted, with the primary dependent variable
being mean daily walking, as assessed by pedometer.
Mixed effects linear models will be fitted to compare
the groups with a random practice effect to allow for
clustering. The models will adjust for baseline character-
istics at both practice and individual level. The former
will include practice size and deprivation index, and the
latter will include age, gender, BMI, ethnicity, employ-
ment status, educational level and clinical condition
leading to referral.
As indicated above, the primary response will be the
mean daily walking distance observed over up to seven
days. Where less than five minutes walking is recorded
for any particular day, the reading for that day will be
treated as missing, and not used in calculating mean
daily duration of walking. When individual days’ data
are missing, so long as data are available for two or
more days, the mean will be taken over these non-miss-
ing days. If no data, or data from fewer than two days,
are available for a particular patient at a particular time-
point, that assessment of walking will be treated as
missing. These missing values will be imputed based on
the baseline characteristics of the practice and individual
[34]. A secondary analyses will be conducted excluding
patients with missing data.
Planned exploratory sub-group analyses will be con-
ducted to determine if the intervention has larger or
smaller effects for groups defined in terms of age, ethni-
city, gender, socio-economic status, or clinical condition,
to provide information on any adverse impacts on social
inequality.
Process evaluation
Formal mediation analyses will be conducted to identify
the mechanisms by which the self-regulation interven-
tion may work. If no clustering effects are found, the
bootstrapping approach recommended by Preacher and
Hayes will be used [35]. However, if clustering effects
are present, then the Preacher and Hayes method would
underestimate standard errors, so the Sobel [36] method
will be used, with standard errors derived from the
mixed effects model. In both instances, changes in TPB
variables over the course of the intervention sessions
(i.e. between t1 and t2) will be examined as potential
mediators of effects on behaviour at t2. Changes in TPB
variables over the course of the entire follow-up period
(i.e. between t1 and t4) will be examined as potential
mediators of effects on behaviour at t4.
Economic evaluation
Economic evaluation methods will, as far as possible,
adhere to the recommendations of the NICE Reference
Case [37]. The economic evaluation will consist of a
within-trial analysis and economic modelling. Within
trial analysis will compare direct costs and six month
outcomes of patients randomised to intervention versus
control. The perspective adopted will be that of the
NHS and Public Social Services. A costing study will
record intervention costs (to include staff time, capital,
overheads and consumables), other NHS resource use
(e.g. general practitioner visits) and patient expenditure.
Unit costs for health care resources will be derived from
local and national sources and performed in line with
best practice [38]. Costs will be standardised to current
prices where possible. Because of the short follow up
period, we will not discount costs or benefits.
Comparison will be made between baseline and 6
months to estimate incremental cost-effectiveness ratios
(ICERs) comparing the intervention with the control
group in terms of the primary outcome measure (mean
daily minutes walked in the past week) and costs [30].
Quality of life (EQ-5D) over the study period will be
used to generate quality-adjusted life-years (QALYs)
[39]. Outputs will be presented as ICERs, cost-effective-
ness acceptability curves and expected net benefit.
Sensitivity analyses will consider key cost drivers and
factors that might affect the outcomes measured in
order to explore uncertainty in the conclusions drawn.
Discussion
The present study will provide a robust estimate of the
effects of a brief walking intervention, when delivered by
PN/HCAs in UK primary care, and the costs associated
with any increases in walking produced. It will address
the current lack of evidence for interventions that are
effective at increasing walking, that can be offered to
patients in primary care [7].
A key strength of this trial is that the evaluated
intervention is built on extended developmental work.
First, the intervention was developed based on explicit
theory [15-17] evidence reviewing [14,23,24], and forma-
tive work [10-14]. Second, the intervention has demon-
strated efficacy in producing large effects (d = 0.90) on
objectively assessed walking of adult volunteers [14].
This effect has been replicated when delivered by a per-
son who was not involved in the development of the
intervention [21]. Third, the intervention has gone
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through a prolonged period of adaptation for delivery by
PN/HCAs in primary care, to optimise fidelity of inter-
vention delivery.
The main outcome of the developmental work in
primary care was that the intervention was extended in
duration from its initial single session format, to a
multi-session format, which was more acceptable to
both recipients and providers. There were slight changes
to the intervention and training materials, to simplify
these where they were unnecessarily complicated. The
intervention materials and training used in the present
trial were therefore acceptable to both recipients and
providers. The fidelity of delivery to the intervention
manual, as assessed at the completion of training has
been consistently good: the PN/HCAs can deliver the
intervention as intended when outside of routine
primary care practice.
The main barrier to the successful delivery of the
intervention by PN/HCAs in the developmental work
undertaken in primary care has not been acceptability to
recipients and providers: it has been the acceptability to
primary care organisations. During the developmental
work, particularly during the trial pilot, it has been
difficult for practices to release the PN/HCAs for the
required training, and to find time in consultation sche-
dules for the delivery of the intervention. This is despite
financial support from the PCRN and PCTs to fully
reimburse practices for the time spent by PN/HCAs on
training and delivery.
The developmental work highlights the importance of
considering applicability and acceptability of behaviour
change interventions to organisations, as well as to
providers and recipients. This is consistent with the
findings of a systematic review and meta-synthesis of
qualitative studies that elicited views and experiences of
nurses involved in the delivery of health behaviour
change interventions in primary care [40]. The meta-
synthesis inductively developed a conceptual framework
of factors key to enhance delivery of behaviour change
interventions by PNs. Although many of the factors
identified had been well described by previous writing
on fidelity generally [25], the influence of healthcare
organisations on fidelity of delivery was clearly essential,
but had previously received little consideration.
Conclusion
The developmental work has adapted an intervention
which has demonstrated efficacy with adult volunteers,
for delivery by PN/HCAs in primary care. This follows
the MRC framework for development and evaluation of
complex interventions [8,9], to optimise the chance of
the intervention demonstrating efficacy when delivered
to primary care patients. If the trial finds the interven-
tion is effective at increasing walking, then the training
programme will be disseminated more widely
throughout primary care, to the benefit of the target
population. However, if the trial finds no effect, the
statistical mediation analyses and explorations of fidelity
in the exploratory (pilot) trial described should identify
why it did not demonstrate efficacy. Potential reasons
include that the intervention was not delivered as
intended, or that it was delivered as intended, but failed
to alter the hypothesised mediators, or that it did alter
the hypothesised mediators but these failed to translate
into behaviour change.
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